Click Here to View VSI Newsletter in Browser


This Newsletter Has Been Generously Sponsored By:

VSI Winter 2019 Newsletter
Bibliography and Sources

Back to Newsletter


Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208–214.

Drucker AM, Qureshi AA, Thompson JM, Li T, Cho E. Gluten intake and risk of psoriasis, psoriatic arthritis and atopic dermatitis among US women [published online August 9, 2019]. J Am Acad Dermatol. doi:10.1016/j.jaad.2019.08.007

Harris JE. "Speaking of Vitiligo. . ." Update on IL-15 vitiligo treatment. Blog. Posted 2020 January 13.

Hu W, Xu Y, et al. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study. Clin Drug Investig. 2019 Dec;39(12):1233-1238.

Mu EW, Cohen BE, Orlow SJ. Early-onset childhood vitiligo is associated with a more extensive and progressive course. J Am Acad Dermatol. 2015 Sep;73(3):467-70. Epub 2015 June 26.

Palmer, WJ. Breakthrough vitiligo treatment offers longer-lasting results. Dermatology Times. epub 2019 March 2.

Copyright © 2020 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission

A Vitiligo Support International, Inc. financial statement is available upon written request from the Virginia Office of Consumer Affairs.
Mail requests to: Virginia Department of Agriculture and Consumer Services, Office of Consumer Affairs, P.O. Box 1163, Richmond, Virginia 23218.
Unsubscribe from the original email